References
- Taylor P. Anticholinesterase agents. The Pharmacological Basis of Therapeutics6th ed., L. S. Goodman, A. Gilman. Macmillan, New York 1980; 100–119
- Funckes A. J. Treatment of severe parathion poisoning with 2-pyridine aldoxime methiodide (2-PAM). Arch. Environ. Health 1960; 1: 404–406
- Jabocziner H., Raybin H. W. Parathion poisoning successfully treated with 2-PAM (pralidoxime chloride). New Engl. J. Med. 1961; 265: 436–437
- Quinby G. E. Further therapeutic experience with pralidoximes in organic phosphorus poisoning. J. Am. Med. Assoc. 1964; 187: 202–206
- Namba T., Nolte C. T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am. J. Med. 1971; 50: 475–492
- Grob D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. Arch. Intern. Med. 1956; 98: 221–239
- Jager B. V., Stagg G. N. Toxicity of diacetylmonoxime and of pyridine-2-aldoxime methiodide in man. Bull. John Hopkins Hosp. 1958; 102: 203–211
- Elliot H. W., Bokums J. A. Effect of pralidoxime on electrical activity of the cat brain. Proc. Soc. Exp. Biol. Med. 1968; 129: 443–446
- Longo V. G., Nachmansohn D., Bovet D. Aspects electroen-cephalographiques de l'antagonisme entre le iodemethylate de 2-pyridine aldoxime (PAM) et le methylfluorophosphate d'isopropyle (Sarin). Arch. Int. Pharmacodyn. 1960; 123: 282–290
- Natoff I. L. The effects of antidotes in experimental animals intoxicated by carbamate and organophosphorus cholinesterase inhibitors. Medical Protection Against Chemical Warfare Agents (Stockholm International Peace Research Institute, ed.). Almquist & Wiskell, Uppsala 1976; 53–63
- Firemark H., Barlow C. F., Roth L. J. The penetration of 2-PAM-C14 into brain and the effect of cholinesterase inhibitors of its transport. J. Pharmacol. Exp. Ther. 1964; 145: 252–265
- Jager B. V., Stagg G. N., Green N., Jager L. Studies on distribution and disappearance of pyridine-2-aldoxime methiodide (PAM) and of diacetylmonoxime (DAM) in man and in experimental animals. Bull. John Hopkins Hosp. 1958; 102: 225–234
- Erdmann W. D. Vergleichende Untersuchungen über das Penetrations-vermögen einiger esteraseaktivierender oxime in das zentrale nerven system. Arzneimittelforshung 1965; 15: 135–139
- Miloševic M. P., Andjelković D. Reactivation of paraoxan-inactivated cholinesterase in the rat cerebral cortex by pralid-oxime chloride. Nature 1966; 210: 206
- Hobbinger F., Vojvodić V. The reactivation of pyridinium aldoximes of phosphyrylated acetylcholinesterase in the central nervous system. Biochem. Pharmacol. 1967; 16: 455–462
- Rosenberg P. In vivo reactivation by PAM of brain cholinesterase inhibited by paraoxon. Biochem. Pharmacol. 1960; 3: 212–219
- Koelle G. B. Handbuch der Experimentellen Pharmakologie, O. Eichler, A. Farah. Springer, Berlin 1963; Vol. 15
- Barnes J. M. Anticholinesterases: Some problems in under-standing their effects in whole animals. Forensic Toxicology, B. Ballantyne, Wright 1974; 79–85
- Murphy S. Pesticides. Casarett Doull's Toxicology–The Basic Science of Poisoning, C. Doull. Macmillan, New York 1980; 357–408
- Sidell F. R., Groff W. A., Ellin R. I. Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride. J. Pharm. Sci. 1969; 58: 1093–1098
- Namba T. Cholinesterase inhibition by organophosphorus compounds and its clinical effects. Bull. W. H. O. 1971; 44: 298–307
- Van der Meer C., Wolthius O. L. The effect of oximes on isolated organs intoxicated with organophosphorus anticholin-esterases. Biochem. Pharmacol. 1965; 14: 1299–1312